Pharmacokinetic properties and drug interactions of apigenin, a natural flavone

References

• Miean KH, Mohamed S. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem. 2001; 49(6):3106–3112.
   PubMed Web of Science ®Google Scholar
• Yang RY, Lin S, Kuo G. Content and distribution of flavonoids among 91 edible plant species. Asia Pac J Clin Nutr. 2008; 17(1):275–279.
   PubMed Web of Science ®Google Scholar
• McKay DL, Blumberg JB. A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res. 2006;20(7):519–530.
   PubMed Web of Science ®Google Scholar
• Škerget M, Kotnik P, Hadolin M, et al. Phenols, proanthocyanidins, flavones and flavonols in some plant materials and their antioxidant activities. Food Chem. 2005;89:191–198.
   Web of Science ®Google Scholar
• Proestos C, Chorianopoulos N, Nychas GJ, et al. RP-HPLC analysis of the phenolic compounds of plant extracts. investigation of their antioxidant capacity and antimicrobial activity. J Agric Food Chem. 2005;53(4):1190–1195.
   PubMed Web of Science ®Google Scholar
• Hertog MGL, Hollman PCH, Venema DP. Optimization of a quantitative HPLC determination of potentially anticarcinogenic flavonoids in vegetables and fruits. J Agric Food Chem. 1992;40(9):1591–1598.
   Web of Science ®Google Scholar
• Lefort ÉC, Blay J. Apigenin and its impact on gastrointestinal cancers. Mol Nutr Food Res. 2013;57(1):126–144.
   PubMed Web of Science ®Google Scholar
• Simirgiotis MJ, Schmeda-Hirschmann G, Bórquez J, et al. The Passiflora tripartita (banana passion) fruit: a source of bioactive flavonoid C-glycosides isolated by HSCCC and characterized by HPLC–DAD–ESI/MS/MS. Molecules. 2013;18(2):1672–1692.
   PubMed Web of Science ®Google Scholar
• Czeczot H, Tudek B, Kusztelak J, et al. Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs. Mutat Res. 1990;240(3):209–216.
   PubMed Web of Science ®Google Scholar
• Patel D, Shukla S, Gupta S. Apigenin and cancer chemoprevention: progress, potential and promise (review). Int J Oncol. 2007;30(1):233–245.
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Yasuda T, Ueda J, et al. Antidepressant-like effects of apigenin and 2,4,5-trimethoxycinnamic acid from Perilla frutescens in the forced swimming test. Biol Pharm Bull. 2003;26(4):474–480.
   PubMed Web of Science ®Google Scholar
• Weng L, Guo X, Li Y, et al. Apigenin reverses depression-like behavior induced by chronic corticosterone treatment in mice. Eur J Pharmacol. 2016;774:50–54.
   PubMed Web of Science ®Google Scholar
• Li R, Zhao D, Qu R, et al. The effects of apigenin on lipopolysaccharide-induced depressive-like behavior in mice. Neurosci Lett. 2015;594:17–22.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu YT, Xiao L, et al. Anti-inflammatory effects of apigenin in lipopolysaccharide-induced inflammatory in acute lung injury by suppressing COX-2 and NF-kB pathway. Inflammation. 2014;37(6):2085–2090.
   PubMed Web of Science ®Google Scholar
• Basios N, Lampropoulos P, Papalois A, et al. Apigenin attenuates inflammation in experimentally induced acute pancreatitis-associated lung injury. J Invest Surg. 2015;2:1–7.
   Google Scholar
• Ali F, Rahul, Naz F, et al. Protective effect of apigenin against N-nitrosodiethylamine (NDEA)-induced hepatotoxicity in albino rats. Mutat Res Genet Toxicol Environ Mutagen. 2014;767:13–20.
   PubMed Web of Science ®Google Scholar
• Yang J, Wang XY, Xue J, et al. Protective effect of apigenin on mouse acute liver injury induced by acetaminophen is associated with increment of hepatic glutathione reductase activity. Food Funct. 2013;4(6):939–943.
   PubMed Web of Science ®Google Scholar
• Janssen K, Mensink RP, Cox FJ, et al. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr. 1998;67(2):255–262.
   PubMed Web of Science ®Google Scholar
• Chiang LC, Ng LT, Lin IC, et al. Anti-proliferative effect of apigenin and its apoptotic induction in human HepG2 cells. Cancer Lett. 2006;237(2):207–214.
   PubMed Web of Science ®Google Scholar
• Chan LP, Chou TH, Ding HY, et al. Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin. Biochim Biophys Acta. 2012;1820(7):1081–1091.
   PubMed Web of Science ®Google Scholar
• Lim H, Park H, Kim HP. Effects of flavonoids on senescence-associated secretory phenotype formation from bleomycin-induced senescence in BJ fibroblasts. Biochem Pharmacol. 2015;96(4):337–348.
   PubMed Web of Science ®Google Scholar
• An F, Cao X, Qu H, et al. Attenuation of oxidative stress of erythrocytes by the plant-derived flavonoids vitexin and apigenin. Pharmazie. 2015;70(11):724–732.
   PubMed Web of Science ®Google Scholar
• Mira L, Fernandez MT, Santos M, et al. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res. 2002;36(11):1199–1208.
   PubMed Web of Science ®Google Scholar
• Barlas N, Özer S, Karabulut G. The estrogenic effects of apigenin, phloretin and myricetin based on uterotrophic assay in immature Wistar albino rats. Toxicol Lett. 2014;226(1):35–42.
   PubMed Web of Science ®Google Scholar
• Wong TY, Lin SM, Leung LK. The flavone apigenin blocks nuclear translocation of sterol regulatory element-binding protein-2 in the hepatic cells WRL-68. Br J Nutr. 2015;113(12):1844–1852.
   PubMed Web of Science ®Google Scholar
• Escande C, Nin V, Price NL, et al. Flavonoid apigenin is an inhibitor of the NAD+ase CD38 implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes. 2013;62(4):1084–1093.
   PubMed Web of Science ®Google Scholar
• Osada M, Imaoka S, Funae Y. Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1alpha protein. FEBS Lett. 2004;575(1–3):59–63.
   PubMed Web of Science ®Google Scholar
• Johnson JL, Rupasinghe SG, Stefani F, et al. Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity. J Med Food. 2011;14(4):325–333.
   PubMed Web of Science ®Google Scholar
• Shukla S, Gupta S. Apigenin: a promising molecule for cancer prevention. Pharm Res. 2010;27(6):962–978.
   PubMed Web of Science ®Google Scholar
• Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl. 1990;201:3–23.
   PubMedGoogle Scholar
• Gupta S, Afaq F, Mukhtar H. Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem Biophys Res Commun. 2001;287:914–920.
   PubMed Web of Science ®Google Scholar
• Lakshmanan A, Scarberry D, Green JA, et al. Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin. Oncotarget. 2015;6(31):31792–31804.
   PubMed Web of Science ®Google Scholar
• Ye L, Chan FL, Chen S, et al. The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice. J Nutr Biochem. 2012;23(10):1230–1237.
   PubMed Web of Science ®Google Scholar
• Saarinen N, Joshi SC, Ahotupa M, et al. No evidence for the in vivo activity of aromatase-inhibiting flavonoids. J Steroid Biochem Mol Biol. 2001;78:231–239.
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Liu DP, Huang YT, et al. Biopharmaceutics classification and intestinal absorption study of apigenin. Int J Pharm. 2012;436:311–317.
   PubMed Web of Science ®Google Scholar
• Li B, Robinson DH, Birt DF. Evaluation of properties of apigenin and [G-3H]apigenin and analytic method development. J Pharm Sci. 1997;86(6):721–725.
   PubMed Web of Science ®Google Scholar
• Block MJ. Chemcycolpedia. Washington (DC): American Chemical Society; 2000. p. 106–107.
   Google Scholar
• Ding SM, Zhang ZH, Cheng XD, et al. Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersion. Int J Nanomedicine. 2014;9:2327–2333.
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Huang YT, Liu DP, et al. Preparation of apigenin nanocrystals using supercritical antisolvent process fordissolution and bioavailability enhancement. Eur J Pharm Sci. 2013;48:740–747.
   PubMed Web of Science ®Google Scholar
• Zhao LL, Zhang L, Meng L, et al. Design and evaluation of a self-micro emulsifying drug delivery system for apigenin. Drug Dev Ind Pharm. 2013;39(5):662–669.
   PubMed Web of Science ®Google Scholar
• Liu Y, Hu M. Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model. Drug Metab Dispos. 2002;30(4):370–377.
   PubMed Web of Science ®Google Scholar
• Pforte H, Hempel J, Jacobasch G. Distribution pattern of a flavonoid extract in the gastrointestinal lumen and wall of rats. Nahrung. 1999;43(3):205–208.
   PubMedGoogle Scholar
• Chen J, Lin H, Hu M. Metabolism of flavonoids via enteric recycling: role of intestinal disposition. J Pharmacol Exp Ther. 2003;304:1228–1235.
   PubMed Web of Science ®Google Scholar
• Li B, Birt DF. In vivo and in vitro percutaneous absorption of cancer preventive flavonoid apigenin in different vehicles in mouse skin. Pharm Res. 1996;13(11):1710–1715.
   PubMed Web of Science ®Google Scholar
• Li B, Pinch H, Birt DF. Influence of vehicle, distant topical delivery, and biotransformation on the chemopreventive activity of apigenin, a plant flavonoid, in mouse skin. Pharm Res. 1996;13(10):1530–1534.
   PubMed Web of Science ®Google Scholar
• Gradolatto A, Basly JP, Berges R, et al. Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration. Drug Metab Dispos. 2005;33:49–54.
   PubMed Web of Science ®Google Scholar
• Wan L, Guo C, Yu Q, et al. Quantitative determination of apigenin and its metabolism in rat plasma after intravenous bolus administration by HPLC coupled with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;855(2):286–289.
   PubMed Web of Science ®Google Scholar
• Chen Z, Tu M, Sun S, et al. The exposure of luteolin is much lower than that of apigenin in oral administration of flos chrysanthemi extract to rats. Drug Metab Pharmacokinet. 2012;27(1):162–168.
   PubMed Web of Science ®Google Scholar
• Chen Z, Ying X, Meng S, et al. High-performance liquid chromatographic determination and pharmacokinetic study of apigenin-7-O-β-D-glucoside in rat plasma after intravenous administration. Arch Pharm Res. 2011;34(5):741–746.
   PubMed Web of Science ®Google Scholar
• Meyer H, Bolarinwa A, Wolfram G, et al. Bioavailability of apigenin from apiin-rich parsley in humans. Ann Nutr Metab. 2006;50:167–172.
   PubMed Web of Science ®Google Scholar
• Teng Z, Yuan C, Zhang F, et al. Intestinal absorption and first-pass metabolism of polyphenol compounds in rat and their transport dynamics in Caco-2 cells. PLoS One. 2012;7(1):e29647.
   PubMed Web of Science ®Google Scholar
• Chen Z, Ying X, Meng S, et al. LC determination of luteolin-7-O-β-D-glucoside and apigenin-7-O-β-D-glucoside in rat plasma after administration of Humulus scandens extract and its application to pharmacokinetic studies. Nat Prod Res. 2012;26(6):530–539.
   PubMed Web of Science ®Google Scholar
• Chen T, Li LP, Lu XY, et al. Absorption and excretion of luteolin and apigenin in rats after oral administration of Chrysanthemum morifolium extract. J Agric Food Chem. 2007;55(2):273–277.
   PubMed Web of Science ®Google Scholar
• Cai H, Boocock DJ, Steward WP, et al. Tissue distribution in mice and metabolism in murine and human liver of apigenin and tricin, flavones with putative cancer chemopreventive properties. Cancer Chemother Pharmacol. 2007;60(2):257–266.
   PubMed Web of Science ®Google Scholar
• Tang L, Zhou J, Yang CH, et al. Systematic studies of sulfation and glucuronidation of 12 flavonoids in the mouse liver S9 fraction reveal both unique and shared positional preferences. J Agric Food Chem. 2012;60(12):3223–3233.
   PubMed Web of Science ®Google Scholar
• Gradolatto A, Canivenc-Lavier MC, Basly JP, et al. Metabolism of apigenin by rat liver phase I and phase ii enzymes and by isolated perfused rat liver. Drug Metab Dispos. 2004;32(1):58–65.
   PubMed Web of Science ®Google Scholar
• Griffiths LA, Smith GE. Metabolism of apigenin and related compounds in the rat. Metabolite formation in vivo and by the intestinal microflora in vitro. Biochem J. 1972;128(4):901–911.
   PubMed Web of Science ®Google Scholar
• Wen X, Walle T. Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metab Dispos. 2006;34(10):1786–1792.
   PubMed Web of Science ®Google Scholar
• Galijatovic A, Otake Y, Walle UK, et al. Extensive metabolism of the flavonoid chrysin by human Caco-2 and HepG2 cells. Xenobiotica. 1999;29(12):1241–1256.
   PubMed Web of Science ®Google Scholar
• Hu M, Chen J, Lin H. Metabolism of flavonoids via enteric recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model. J Pharmacol Exp Ther. 2003;307(1):314–321.
   PubMed Web of Science ®Google Scholar
• Spencer JP, Abd-el-Mohsen MM, Rice-Evans C. Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity. Arch Biochem Biophys. 2004;423:148–161.
   PubMed Web of Science ®Google Scholar
• Day AJ, DuPont MS, Ridley S, et al. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett. 1998;436(1):71–75.
   PubMed Web of Science ®Google Scholar
• Nielsen SE, Breinholt V, Justesen U, et al. In vitro biotransformation of favonoids by rat liver microsomes. Xenoiotica. 1998;28(4):389–401.
   PubMed Web of Science ®Google Scholar
• Galati G, Moridani MY, Chan TS, et al. Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation. Free Radic Biol Med. 2001;30(4):370–382.
   PubMed Web of Science ®Google Scholar
• Nielsen SE, Young JF, Daneshvar B, et al. Effect of parsley (Petroselinum crispum) intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress in human subjects. Br J Nutr. 1999;81(6):447–455.
   PubMed Web of Science ®Google Scholar
• Hanske L, Loh G, Sczesny S, et al. The bioavailability of apigenin-7-glucoside is influenced by human intestinal microbiota in rats. J Nutr. 2009;139(6):1095–1102.
   PubMed Web of Science ®Google Scholar
• Shukla S, Maclennan GT, Fu P, et al. Apigenin attenuates insulin-like growth factor-I signaling in anautochthonous mouse prostate cancer model. Phar Res. 2012;29(6):1506–1517.
   Web of Science ®Google Scholar
• Seo YJ, Kim BS, Chun SY, et al. Apoptotic effects of genistein, biochanin-A and apigenin on LNCaP and PC-3 cells by p21 through transcriptional inhibition of polo-like kinase-1. J Korean Med Sci. 2011;26(11):1489–1494.
   PubMed Web of Science ®Google Scholar
• Pandey M, Kaur P, Shukla S, et al. Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study. Mol Carcinog. 2012;51(12):952–962.
   PubMed Web of Science ®Google Scholar
• Nagaprashantha LD, Vatsyayan R, Singhal J, et al. Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer. Biochem Pharmacol. 2011;82(9):1100–1109.
   PubMed Web of Science ®Google Scholar
• Wong IL, Chan KF, Tsang KH, et al. Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives. J Med Chem. 2009;52(17):5311–5322.
   PubMed Web of Science ®Google Scholar
• Li ZD, Hu XW, Wang YT, et al. Apigenin inhibits proliferation of ovarian cancer A2780 cells through Id1. FEBS Lett. 2009;583(12):1999–2003.
   PubMed Web of Science ®Google Scholar
• Luo H, Jiang BH, King SM, et al. Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids. Nutr Cancer. 2008;60(6):800–809.
   PubMed Web of Science ®Google Scholar
• Hu XW, Meng D, Fang J. Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Carcinogenesis. 2008;29(12):2369–2376.
   PubMed Web of Science ®Google Scholar
• Fang J, Zhou Q, Liu LZ, et al. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. Carcinogenesis. 2007;28(4):858–864.
   PubMed Web of Science ®Google Scholar
• Liu Q, Chen X, Yang G, et al. Apigenin inhibits cell migration through MAPK pathways in human bladder smooth muscle cells. Biocell. 2011;35(3):71–79.
   PubMed Web of Science ®Google Scholar
• Kilani-Jaziri S, Frachet V, Bhouri W, et al. Flavones inhibit the proliferation of human tumor cancer cell lines by inducing apoptosis. Drug Chem Toxicol. 2012;35(1):1–10.
   PubMed Web of Science ®Google Scholar
• Turktekin M, Konac E, Onen HI, et al. Evaluation of the effects of the flavonoid apigenin on apoptotic pathway gene expression on the colon cancer cell line (HT29). J Med Food. 2011;14(10):1107–1117.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Krisanapun C, Lee SH, et al. Molecular targets of apigenin in colorectal cancer cells: involvement of p21, NAG-1 and p53. Eur J Cancer. 2010;46(18):3365–3374.
   PubMed Web of Science ®Google Scholar
• Leonardi T, Vanamala J, Taddeo SS, et al. Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats. Exp Biol Med (Maywood). 2010;235(6):710–717.
   PubMed Web of Science ®Google Scholar
• Masuelli L, Marzocchella L, Quaranta A, et al. Apigenin induces apoptosis and impairs head and neckcarcinomas EGFR/ErbB2 signaling. Front Biosci. 2011;16:1060–1068.
   Web of Science ®Google Scholar
• Franek KJ, Zhou Z, Zhang WD, et al. In vitro studies of baicalin alone or in combination with Salvia miltiorrhiza extract as a potential anti-cancer agent. Int J Oncol. 2005;26(1):217–224.
   PubMed Web of Science ®Google Scholar
• Lee SH, Ryu JK, Lee KY, et al. Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. Cancer Lett. 2008;259(1):39–49.
   PubMed Web of Science ®Google Scholar
• Johnson JL, Gonzalez De Mejia E. Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro. Food Chem Toxicol. 2013;60:83–91.
   PubMed Web of Science ®Google Scholar
• Xu Y, Xin Y, Diao Y, et al. Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells. PLoS One. 2011;6(12):e29169.
   PubMed Web of Science ®Google Scholar
• Choi SJ, Choi JS. The promotive effects of antioxidative apigenin on the bioavailability of paclitaxel for oral delivery in rats. Biomolecules Ther. 2010;18(4):469–476.
   Web of Science ®Google Scholar
• Kumar KK, Priyanka L, Gnananath K, et al. Pharmacokinetic drug interactions between apigenin, rutin and paclitaxel mediated by P-glycoprotein in rats. Eur J Drug Metab Pharmacokinet. 2015;40(3):267–276.
   PubMed Web of Science ®Google Scholar
• Hu XY, Liang JY, Guo XJ, et al. 5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (ΔΨm)-mediated apoptosis in hepatocellular carcinoma. Clin Exp Pharmacol Physiol. 2015;42(2):146–153.
   PubMed Web of Science ®Google Scholar
• Choi EJ, Kim GH. 5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells. Oncol Rep. 2009;22(6):1533–1537.
   PubMed Web of Science ®Google Scholar
• Choudhury D, Ganguli A, Dastidar DG, et al. Apigenin shows synergistic anticancer activity with curcumin by binding at different sites of tubulin. Biochimie. 2013;95(6):1297–1309.
   PubMed Web of Science ®Google Scholar
• Kim SH, Kang JG, Kim CS, et al. Akt inhibition enhances the cytotoxic effect of apigenin in combination with PLX4032 in anaplastic thyroid carcinoma cells harboring BRAFV600E. J Endocrinol Invest. 2013;36(11):1099–1104.
   PubMed Web of Science ®Google Scholar
• Mohan N, Banik NL, Ray SK. Combination of N-(4-hydroxyphenyl) retinamide and apigenin suppressed starvation-induced autophagy and promoted apoptosis in malignant neuroblastoma cells. Neurosci Lett. 2011;502(1):24–29.
   PubMed Web of Science ®Google Scholar
• Chuang CM, Monie A, Wu A, et al. Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects. J Biomed Sci. 2009;16:49.
   PubMed Web of Science ®Google Scholar
• Siddique YH, Beg T, Afzal M. Antigenotoxic effect of apigenin against anti-cancerous drugs. Toxicol In Vitro. 2008;22(3):625–631.
   PubMed Web of Science ®Google Scholar
• Siddique YH, Afzal M. Antigenotoxic effect of apigenin against mitomycin C induced genotoxic damage in mice bone marrow cells. Food Chem Toxicol. 2009;47(3):536–539.
   PubMed Web of Science ®Google Scholar
• Helton WB, Choi EY, Gairola CG, et al. Apigenin and kaempferol effects on oral cancer FADU cells. Otolaryngol Head Neck Surg. 2008;139(2S1):P180.
   Google Scholar
• Liu XY, Xu T, Li WS, et al. The effect of apigenin on pharmacokinetics of imatinib and its metabolite N-desmethyl imatinib in rats. Biomed Res Int. 2013;2013:789184.
   PubMedGoogle Scholar
• Pastrakuljic A, Tang BK, Roberts EA, et al. Distinction of CYP1A1 and CYP1A2 activity by selective inhibition using fluvoxamine and isosafrole. Biochem Pharmacol. 1997;53(4):531–538.
   PubMed Web of Science ®Google Scholar
• Sun QW, Jiang SM, Yang K, et al. Apigenin enhances the cytotoxic effects of tumornecrosis factor-related apoptosis-inducing ligand in human rheumatoid arthritis fibroblast-like synoviocytes. Mol Biol Rep. 2012;39(5):5529–5535.
   PubMed Web of Science ®Google Scholar
• Lu X, Sun D, Chen Z, et al. Evaluation of hepatic clearance and drug-drug interactions of luteolin and apigenin by using primary cultured rat hepatocytes. Pharmazie. 2011;66(8):600–605.
   PubMed Web of Science ®Google Scholar
• Zhan YY, Liang BQ, Gu EM, et al. Inhibitory effect of apigenin on pharmacokinetics of venlafaxine in vivo and in vitro. Pharmacology. 2015;96(3–4):118–123.
   PubMed Web of Science ®Google Scholar
• Chen Y, Jia X, Chen J, et al. The pharmacokinetics of raloxifene and its interaction with apigenin in rat. Molecules. 2010;15(11):8478–8487.
   PubMed Web of Science ®Google Scholar
• Eumkeb G, Chukrathok S. Synergistic activity and mechanism of action of ceftazidime and apigenin combination against ceftazidime-resistant Enterobacter cloacae. Phytomedicine. 2013;20(3–4):262–269.
   PubMed Web of Science ®Google Scholar
• Navarro-Núñez L, Lozano ML, Palomo M, et al. Apigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway. J Agric Food Chem. 2008;56(9):2970–2976.
   PubMed Web of Science ®Google Scholar
• Ueno I, Nakano N, Hirono I. Metabolic fate of [14C] quercetin in the ACI rat. Jpn J Exp Med. 1983;53(1):41–50.
   PubMedGoogle Scholar
• Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr. 2002;22:19–34.
   PubMed Web of Science ®Google Scholar